This Common Type of Medication Is Linked to Slower Cognitive Decline
2 Articles
2 Articles
This Common Type of Medication Is Linked to Slower Cognitive Decline
People with atrial fibrillation and Alzheimer’s disease who received NOACs showed a modestly slower rate of cognitive decline. For people living with both Alzheimer’s disease and atrial fibrillation, the type of blood-thinning medication they receive may be linked to how quickly their cognitive abilities decline. Research from Karolinska Institutet, published in the European Heart Journal, [...]
Research conducted by the Karolinska Institutet indicates that patients with Alzheimer's and atrial fibrillation who use non-vitamin K antagonist oral anticoagulants (NOACs) experience a slower rate of cognitive decline compared to those using warfarin or not receiving anticoagulant treatment. The study, published in the European Heart Journal, analyzed data from 7,308 patients diagnosed with atrial fibrillation and Alzheimer's. Participants wer…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
